Tag: mpox
-
Determinants of mpox vaccination uptake among MSM during the 2022 outbreak: A Lyon, France, single-centre retrospective study
Overview The 2022 mpox outbreak prompted targeted vaccination campaigns for men who have sex with men (MSM) at risk. A large retrospective study from Lyon University Hospital, France, assessed first-dose uptake of the modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine among MSM attending STI and HIV clinics between January 2022 and February 2023. The study categorized…
-
Determinants of mpox vaccination uptake among MSM during the 2022 outbreak: Insights from Lyon, France
Overview and context The 2022 mpox outbreak prompted a targeted vaccination campaign for at-risk populations, notably men who have sex with men (MSM) with multiple sexual partners. A large retrospective study from Lyon University Hospital in France evaluated first-dose mpox vaccination (modified vaccinia Ankara-Bavarian Nordic) uptake among MSM and explored several determinants that influenced whether…
-
Determinants of mpox Vaccination Uptake Among MSM During the 2022 Outbreak: Insights from a Lyon Hospital Study
Background and Objectives The 2022 mpox outbreak prompted targeted vaccination for at‑risk groups, notably men who have sex with men (MSM) with multiple partners. Aiming to quantify first-dose uptake and understand its drivers, researchers conducted a single‑centre retrospective analysis at the STI and HIV clinics of Lyon University Hospital, France. The study focused on three…